Treating Patients With Aneurysmal SubArachnoid Hemorrhage (SAH) With Epoetin Alfa "EPO"


Phase 4 Results

Summary of Purpose

This is a prospective, randomized, double-blinded, placebo controlled pilot safety study that will enroll a total of twenty subjects. Subjects will be adults (30-75) who have sustained a SAH secondary to cerebral aneurysm rupture and who present with minimal neurological symptoms. All subjects will have a Hemoglobin less... Trial Stopped: This study is terminated as a result of data from a study that showed increased mortality in stroke patients.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 25 September 2012.

1 Jul 2007 7 Feb 2008 1 Feb 2009 1 Feb 2009 1 Sep 2012 8 Sep 2011
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment


Not available